#ThinkSabio US Market Morning Brief
Pre-Market Gainers:
$SLXN +184% : Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
$MOGU +178%: MOGU Approves Strategic Allocation of Up to US$20 Million to Digital Currencies
$MAZE +63%: Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
*Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
Pre-Market Decliners:
$JBDI -26%
$ZYBT-23%
Pre-Market Penny Gainers:
$PFSA +145% : Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
$YYGH +86%: YY Group Announces Pricing of Registered Offering of Ordinary Shares and Warrants (Sep 10)
Headlines
$ORCL: Oracle Health to Enable Accelerated Payer-Provider Collaboration, Advanced Value-Based Care
$VRTX: Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
$TEM – Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device